Immunome Inc. (IMNM)
NASDAQ · Healthcare
Immunome Inc. Income Statement 2023–2025
| Dec 2025 | Dec 2024 | Dec 2023 | |
|---|---|---|---|
| Revenues | |||
| Revenue | 6.9M | 9.0M | 14.0M |
| Gross Profit | — | — | — |
| Profitability | |||
| Operating Income | -224.1M | -305.8M | -109.5M |
| EBITDA | -221.6M | -304.2M | -109.1M |
| Net Income | -212.4M | -293.0M | -106.8M |
| Per Share Data | |||
| EPS (diluted) | — | — | — |
| Shares Outstanding (dil.) | 87M | 59M | 20M |
Immunome Inc. Income Statement — FAQ
Immunome Inc. (IMNM) income statement over the last 3 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see IMNM's income statement history?
The chart and table above show Immunome Inc.'s income statement by year and by quarter, including the growth rate.